patient_id	feature_display	tested_subfeature	therapy_name	n_mut	n_wt	n_mut_tested	n_wt_tested	mut_ic50_median	mut_ic50_mean	mut_ic50_std	wt_ic50_median	wt_ic50_mean	wt_ic50_std	pvalue_mww	statistic
KIRP-A4-8311	MET Amplification	MET	Crizotinib	199	1624	106	631	24.738	58.372	90.106	25.537	55.528	104.041	0.878	33754.0
KIRP-A4-8311	MET Amplification	MET Copy Number	Crizotinib	117	1706	60	677	24.822	57.83	90.407	25.427	55.769	103.133	0.928	20454.0
KIRP-A4-8311	MET Amplification	MET Copy Number Amplification	Crizotinib	82	1741	42	695	18.828	59.826	100.235	25.554	55.702	102.28	0.59	15317.0
KIRP-A4-8311	PIK3CA Amplification	PIK3CA	Pictilisib	290	1533	162	604	3.216	7.274	12.138	4.1	15.02	75.056	0.019	54787.0
KIRP-A4-8311	PIK3CA Amplification	PIK3CA Copy Number	Pictilisib	146	1677	69	697	4.148	10.287	15.628	3.775	13.688	70.006	0.348	22401.0
KIRP-A4-8311	PIK3CA Amplification	PIK3CA Copy Number Amplification	Pictilisib	127	1696	62	704	3.61	9.228	15.303	3.806	13.747	69.675	0.98	21781.0
KIRP-A4-8311	EGFR Amplification	EGFR	Gefitinib	242	1581	138	614	18.934	31.922	42.565	27.148	45.733	64.802	0.0	50477.5
KIRP-A4-8311	EGFR Amplification	EGFR Copy Number	Gefitinib	139	1684	81	671	20.562	31.526	45.523	26.523	44.607	63.077	0.004	32548.0
KIRP-A4-8311	EGFR Amplification	EGFR Copy Number Amplification	Gefitinib	122	1701	72	680	18.048	31.884	47.851	26.493	44.396	62.721	0.003	29771.0
